Please login to the form below

Not currently logged in
Email:
Password:

The Editors blog

An inside look at what’s happening within the pharma industry and across the PMGroup from the PMLiVE editorial team

Resistance's irresistible need

Industry's anti-infective efforts step up a gear

AntibioticsAntimicrobial resistance. It's not, perhaps, a particularly dynamic topic, but it will be a priority one for 2014, at least as far as the EMA is concerned. 

Finalising its 2014 work programme late last year the European regulator made “tackling the issue of antimicrobial resistance and availability of anti-infective treatment options” one of its focus areas for this year.  

The area has gradually been gaining momentum, especially during the last 12 months, beginning in February when EU efforts to combat the issue saw five major pharma firms partner under the auspices of the Innovative Medicines Initiative's (IMI) New Drugs for Bad Bugs programme.  

As bacterial infections grow increasingly resistant to current treatments, leaving doctors with fewer options, individual companies have made progress on researching new antibiotics.  

Cubist looks to be on track to file its new antibiotic later this year after posting positive phase III data in December and AstraZeneca, despite planning to cut back on its anti-infectives research, forged a new partnership in November with Singapore's main research centre.  

As was noted on PMLiVE recently, the discovery of antibacterial drugs was a transformative moment in human history, but increasing resistance demands a global commitment to develop new drugs. Clearly, when antimicrobial resistance still causes 25,000 deaths each year, the need for pharma successes in this area is irresistible.

Article by
Dominic Tyer

editorial director of PMGroup

14th January 2014

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Just::Health Communications

Just:: is a different kind of healthcare communications agency. Since 2006, we’ve been collaborating with clients around the world to...

Latest intelligence

The gene therapy revolution
Gene therapies are bringing new hope for many people with diseases caused by genetic disorders...
PM Society Digital Awards – the power of together
Our chief executive, Emma Statham, writes about the value of awards and the power of together....
Seduction_feature_image_thumb.jpg
Seduce anyone in four simple steps
You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...

Infographics